S
This company develops glucose-responsive insulin that automatically adjusts to blood sugar levels, eliminating the need for multiple daily injections. Their insulin aims to simplify diabetes management by combining basal and prandial insulin delivery into a single formulation, reducing the burden of frequent glucose monitoring.
Updated 16 months ago
Funding
Funding not disclosed
CVFunding rounds are not available yet.
Founders
Product
Features
- This company develops glucose-responsive insulin that automatically adjusts to blood sugar levels, eliminating the need for multiple daily injections. Their insulin aims to simplify diabetes management by combining basal and prandial insulin delivery into a single formulation, reducing the burden of frequent glucose monitoring.